Mode
Text Size
Log in / Sign up

Neurology

517 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Valproic Acid Oral Solution (valproic acid) for Complex Partial and Absence Seizures.
Neurology FDA Approval
FDA Approves Valproic Acid Oral Solution (valproic acid) for Complex Partial and Absence Seizures. The FDA has approved a liquid form of an older seizure medicine called valproic acid.
Valproic acid oral solution is approved as monotherapy and adjunctive therapy for complex partial seizures and for simple and complex absenc…
The FDA approved a liquid version of valproic acid to help adults and children over 10 manage complex partial and absence seizures when pill…
FDA Approves Valproic Acid Oral Solution (valproic acid) for Monotherapy and Adjunctive Therapy of Complex Partial and Absence Seizures
Neurology FDA Approval
FDA Approves Valproic Acid Oral Solution (valproic acid) for Monotherapy and Adjunctive Therapy of Complex Partial and Absence Seizures The FDA has approved a liquid form of an existing epilepsy and migraine prevention medicine.
The FDA has approved valproic acid oral solution for monotherapy and adjunctive therapy of complex partial seizures, and as sole and adjunct…
The FDA approved a liquid version of valproic acid, an established epilepsy and migraine medicine, offering an easier swallowing option for …
Digital memory assessment and plasma pTau217 identify preclinical Alzheimer's disease participants at elevated risk for progression.
Neurology RCT
Digital memory assessment and plasma pTau217 identify preclinical Alzheimer's disease participants at elevated risk for progression. Two simple tests may help find early Alzheimer's risk faster
This analysis of data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study evaluated cognitively unimpaired, amylo…
Two simple tests can spot older adults at high risk for Alzheimer's decline, helping doctors find the right patients faster for new treatmen…
AI approaches show potential for mapping brain-heart network interactions in neurocardiology
Neurology Sys. Review
AI approaches show potential for mapping brain-heart network interactions in neurocardiology Can AI help us understand the hidden conversation between our brain and heart?
A systematic review explores artificial intelligence approaches for mapping and predicting brain-heart network dynamics across conditions li…
Artificial intelligence may decode the silent conversation between your brain and heart to spot hidden patterns in conditions like heart fai…
Direct Transfer to Angiography Suite Shows No Benefit, Higher Hemorrhage Risk in Severe Stroke
Neurology RCT
Direct Transfer to Angiography Suite Shows No Benefit, Higher Hemorrhage Risk in Severe Stroke Does rushing stroke patients straight to treatment improve their recovery?
A randomized trial in 115 adults with acute severe stroke from large vessel occlusion compared direct transfer to angiography suite (DTAS) w…
Skipping the CT scan to rush stroke patients straight to treatment did not improve recovery and increased the risk of serious brain bleeding…
Neuromodulation for pediatric disorders of consciousness lacks specific pediatric evidence
Neurology Sys. Review
Neuromodulation for pediatric disorders of consciousness lacks specific pediatric evidence Review finds limited evidence for brain stimulation in children with consciousness disorders
A systematic review synthesized adult-derived evidence for neuromodulation (tDCS, rTMS, DBS) in pediatric disorders of consciousness. Transl…
Brain stimulation for children with consciousness disorders lacks safety proof because kids' developing brains differ from adults, creating …
Plasma biomarkers diverge sequentially up to 26 years before symptom onset in autosomal dominant Alzheimer's disease
Neurology Cohort
Plasma biomarkers diverge sequentially up to 26 years before symptom onset in autosomal dominant Alzheimer's disease Can a blood test spot Alzheimer's risk decades before symptoms appear?
A longitudinal cohort study of 73 ADAD mutation carriers and 40 non-carriers found eight plasma biomarkers elevated sequentially from 26 to …
A blood test can spot Alzheimer's risk up to 26 years before symptoms appear in people with a specific inherited gene mutation.
Modeling suggests 30% Parkinson's progression reduction may lower 10-year milestone risks
Neurology Cohort
Modeling suggests 30% Parkinson's progression reduction may lower 10-year milestone risks Study models how slowing Parkinson's progression might reduce long-term risks
An observational cohort study of Parkinson's disease patients from the Oxford Parkinson's Disease Centre modeled a hypothetical 30% reductio…
Slowing Parkinson's disease progression by 30% could reduce long-term risks like dementia, falls, and death by up to 7.5% over 10 years, acc…
Carotid PWV and TyG index may help discriminate LAA from SVO in acute ischemic stroke
Neurology Cohort
Carotid PWV and TyG index may help discriminate LAA from SVO in acute ischemic stroke Could a simple test help doctors quickly identify the type of stroke?
A single-center retrospective cohort study of 298 acute ischemic stroke patients found large-artery atherosclerosis (LAA) patients had highe…
Doctors might soon spot the cause of a stroke faster by checking neck artery stiffness and blood sugar levels.
Preoperative CSF metabolic profiles associated with recovery potential after shunt placement for NPH
Neurology Cohort
Preoperative CSF metabolic profiles associated with recovery potential after shunt placement for NPH Can fluid chemistry before surgery predict who will walk and think better after shunt placement?
A cohort study of patients undergoing shunt placement for normal pressure hydrocephalus found preoperative cerebrospinal fluid metabolite pr…
Spinal fluid chemistry before shunt surgery can predict which patients will see better walking and thinking results after the procedure.
Greater cognitive variability in NSD Stage 2 predicts progression to advanced stages in observational study
Neurology
Greater cognitive variability in NSD Stage 2 predicts progression to advanced stages in observational study Could a simple test of mental consistency help spot early Parkinson's disease?
An observational study of 934 participants from the Parkinson's Progression Markers Initiative found that greater intraindividual cognitive …
A simple mental consistency test can spot early Parkinson's disease signs before obvious symptoms appear, helping predict who will progress …
Resting-state fMRI shows reduced brain entropy in episodic and chronic migraine compared to healthy controls.
Neurology
Resting-state fMRI shows reduced brain entropy in episodic and chronic migraine compared to healthy controls. Brain entropy changes in migraine patients compared to healthy controls
This resting-state fMRI study examined brain entropy in adults with episodic migraine, chronic migraine, and healthy controls. Results indic…
Migraine patients show lower brain complexity in key networks compared to healthy controls, with the biggest drop seen in chronic cases.